Less time on data.More time with patients.

Sensitization profiles and clinical phenotypes of 348 children and 467 adults with seasonal allergic rhinitis, recruited with a uniform methodology across nine cities in seven Southern European countries.

Clinical data, molecular sIgE and e-diary outcomes recorded through the pollen season are used to predict the result of the nasal provocation test in poly-sensitized children.

A review of the mHealth apps usable to collect real-world data on allergen immunotherapy: of the five with scientific publications, only MASK-air and AllergyMonitor cover patients under immunotherapy.

A comparison between severity measured day by day with the e-diary and severity reconstructed retrospectively with the ARIA classification: two measures that do not coincide in clinical practice.

Of more than 1,500 rhinitis and rhinosinusitis apps surveyed in the app stores, only six have published results in the scientific literature. AllergyMonitor is one of them.

Identifies the parameters that estimate the intrinsic quality of patient-entered data beyond mere recording completeness — a prerequisite for relying on the diary in clinical decisions.

Analysis of the consistency between symptom and medication scores in 101 children and 93 adults recording daily data with AllergyMonitor: validity holds at population level but varies from patient to patient.

Among 815 patients with seasonal allergic rhinitis, 20.5% report pollen food allergy syndrome reactions, most often triggered by kiwi, peach and melon.

A fuzzy clustering method for functional data applied to longitudinal mobile health series, to identify patient clusters on which differentiated therapies can be built.

A synthesis of ten years of clinical studies and routine practice with AllergyMonitor (TPS, Rome) since 2009: etiologic diagnosis by matching symptoms with pollen counts, short-term symptom prediction, adherence measurement.

Adherence to an e-diary prescribed by the allergist within a blended care pathway is far higher than that observed for spontaneously downloaded apps. Cohort of 101 children and 93 adults.

EAACI pollen season definitions, designed for Northern Europe, fragment into up to eight segments across the six Mediterranean cities analysed — a direct problem for immunotherapy trial design.

401 children from the "Panallergens in Pediatrics" cohort re-examined six years later; the structured clinical history was collected with AllergyCARD at both baseline and follow-up.

1,120 children with grass pollen rhinoconjunctivitis, standardized questionnaires acquired through AllergyCARD: 87 distinct sensitization profiles across the eight Phleum pratense molecules.

Six severity scores compared against pollen counts in cohorts from Ascoli and Berlin: the platform automatically generates one symptom score and five symptom-medication scores from the same data.

A 15-variable predictive model (date, weather, airborne concentration of five pollen taxa, IgE sensitization intensity) forecasting the individual patient's symptoms in the short term.

A randomized controlled trial: children followed with AllergyMonitor telemonitoring versus usual care with no diary. Adherence to nasal corticosteroid was measured by weighing the canisters, not self-reported.

1,360 children recruited across 16 pediatric allergy clinics in 14 Italian cities, with standardized atopy questionnaires collected on the platform: prevalence and determinants of pollen-induced rhinitis severity.

Description of the ScoradCard software for computer-aided lesion mapping in the calculation of the SCORAD index in atopic dermatitis.

Twenty pediatricians untrained in skin assessment estimated the involved body surface area first by sight, then with ScoradCard: by sight the estimate deviates from the gold standard, with the software it does not.